| Deal value | $5.7B |
|---|---|
| Share of market cap | 276.4% |
| Share of annual revenue | 172.3% |
Key highlights
- Shareholders to receive $23.50 per share in cash, representing a substantial premium over current trading levels
- Total enterprise value of the transaction is approximately $5.7 billion including assumed debt
- Bain Capital Private Equity will roll over its existing shares into the new private parent entity
- The acquisition integrates over 200 surgical locations across 30 states into a national platform
- Transaction is expected to close in the first quarter of 2027 following regulatory approvals
What Is the Deal?
Surgery Partners, Inc. has entered into a definitive merger agreement with Spyglass Topco, LLC and Spyglass Merger Subsidiary, Inc., entities affiliated with HealthSpan Partners and Bon Secours Mercy Health. The all-cash transaction values the short-stay surgical provider at an enterprise value of $5.7 billion. Under the terms, unaffiliated shareholders will receive $23.50 per share in cash at closing. Bain Capital, the company’s largest stakeholder, has agreed to roll over its equity interests into the acquiring entity, ensuring it remains a significant partner in the combined outpatient surgical care business alongside HealthSpan Partners. The acquisition is slated for completion in early 2027.
Deal Structure & Terms
- Public stockholders receive $23.50 per share in cash, excluding Rollover Shares
- Bain Capital affiliates to exchange common stock for equity in Spyglass Topco, LLC
- Transaction was recommended by a Special Committee of independent and disinterested directors
- Bon Secours Mercy Health serves as the guarantor for the merger obligations
- The agreement includes customary closing conditions, including stockholder and regulatory approvals
Strategic Rationale
The acquisition creates one of the largest outpatient surgical care platforms in the United States by merging Surgery Partners’ specialized facilities with HealthSpan Partners’ clinical network. Surgery Partners brings a national footprint of more than 200 ambulatory surgery centers and surgical hospitals, supported by approximately 5,000 affiliated physicians. The combined entity will focus on high-growth specialties including orthopedics, cardiology, and ophthalmology. This move follows a period of portfolio optimization for Surgery Partners, which recently divested its Idaho Falls facility interests for $795 million to Intermountain Health to focus on its core national platform expansion.
Financial Context
Surgery Partners reported annual revenue of $3.31 billion and recently updated its full-year 2026 revenue guidance to a range of $3.08 billion to $3.18 billion. The $23.50 per share cash offer provides a clear exit for public investors at a valuation significantly above the recent market capitalization of $2.06 billion. The transaction occurs as the company’s stock showed an RSI of 64.2, indicating strong momentum prior to the deal announcement. By moving to a private structure with a nonprofit-affiliated health system, the company gains access to long-term stewardship and a broader range of care settings across 30 states.
Up 70.1% since our story on 26 Oct: $15.75 when we broke it → $26.79 at the close on 16 Nov. Daily closing prices. Source: Yahoo Finance.
Show the prices
| 19 Oct | $14.71 |
|---|---|
| 20 Oct | $15.49 |
| 21 Oct | $15.40 |
| 22 Oct | $15.90 |
| 23 Oct | $15.75 |
| 26 Oct | $23.25 |
| 27 Oct | $23.36 |
| 28 Oct | $23.24 |
| 29 Oct | $23.21 |
| 30 Oct | $23.21 |
| 2 Nov | $23.12 |
| 3 Nov | $23.13 |
| 4 Nov | $23.16 |
| 5 Nov | $23.17 |
| 6 Nov | $23.20 |
| 9 Nov | $26.45 |
| 10 Nov | $26.73 |
| 11 Nov | $26.66 |
| 12 Nov | $26.58 |
| 13 Nov | $26.95 |
| 16 Nov | $26.79 |
| Date | Announcement | Amount |
|---|---|---|
| 24 Jul 2026 | Sale of ownership interests in Idaho Falls facilities to Intermountain HealthSource: ir.surgerypartners.com | $795.0 Million |
| 04 Mar 2026 | Acquisition of Preferred Vascular Group by Surgery PartnersSource: prnewswire.com | – |
| 08 Dec 2025 | Joint venture partnership with Baylor Scott & White Health to co-own The Physicians Centre HospitalSource: news.bswhealth.com | – |
| 28 Oct 2025 | Partnership with Duly Health and Care on minority acquisition in Valley Ambulatory Surgery CenterSource: businesswire.com | – |
| 28 Jan 2025 | Non-binding buyout proposal received from Bain Capital Private EquitySource: ir.surgerypartners.com | – |
Management commentary
“Our relationship with Surgery Partners represents an important step toward advancing that commitment. Surgery Partners has built a respected national platform rooted in strong physician relationships and a commitment to quality care.”
“Together, we have an opportunity to expand access to high-quality outpatient care while supporting physicians and helping patients receive the right care, in the right setting, at the right time.”
| Share price | $15.75 |
|---|---|
| Market cap | $2.1B |
| Revenue (annual) | $3.3B |
| 1-month price change | +8.17% |
| Sector | HealthcareMedical Care Facilities |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
SEC filing by Surgery Partners, Inc. announcing a definitive merger agreement with HealthSpan Partners for $5.7 billion.
Track Surgery Partners, Inc. live
Get the next Surgery Partners, Inc. SEC filing seconds after it lands.



